Novo Nordisk Allow for Loan/Lease Loss (Quarterly) Trends

Novo Nordisk A/S (NVO)

39.07 +0.57 (+1.48%) USD | NYSE | Mar 05, 16:00

38.73 -0.34 (-0.87%) Pre-Market: 08:30

View Allow for Loan/Lease Loss (Quarterly) for NVO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Allow for Loan/Lease Loss (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Allow for Loan/Lease Loss (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Allow for Loan/Lease Loss (Quarterly) Benchmarks

Start Trial

Ascendis Pharma A/S	--
Evaxion AS	--
Regeneron Pharmaceuticals, Inc.	--
Viking Therapeutics, Inc.	--
DBV Technologies SA	--